300204.SZ
Price:
$27.56
Market Cap:
$13.17B
Staidson (Beijing) BioPharmaceuticals Co., Ltd. primarily engages in the research and development, production, and marketing of therapeutic drugs in China. The company offers protein drugs, including therapeutic monoclonal antibody drugs; gene therapy/cell therapy drugs; and chemical drugs. It principally offers its products under the fields of nervous system related, infectious, gastrointestinal, urinary system, and autoimmune diseases. The company has a strategic collaboration with Pivotal S.L. to assess BDB-001, a monoclonal anti-C5a antibody, in a clinical trial in Europe in progressive severe COVID-19 patients caused by SARS-CoV-2. Staidson (Beijing) BioPharmaceuticals Co., Ltd. was fou...[Read more]
Industry
Biotechnology
IPO Date
2011-04-15
Stock Exchange
SHZ
Ticker
300204.SZ
According to Staidson (Beijing) BioPharmaceuticals Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 13.05B. This represents a change of 26.89% compared to the average of 10.29B of the last 4 quarters.
The mean historical Enterprise Value of Staidson (Beijing) BioPharmaceuticals Co., Ltd. over the last ten years is 6.19B. The current 13.05B Enterprise Value has changed 20.99% with respect to the historical average. Over the past ten years (40 quarters), 300204.SZ's Enterprise Value was at its highest in in the June 2025 quarter at 17.66B. The Enterprise Value was at its lowest in in the June 2024 quarter at 2.72B.
Average
6.19B
Median
5.55B
Minimum
3.52B
Maximum
10.90B
Discovering the peaks and valleys of Staidson (Beijing) BioPharmaceuticals Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 121.03%
Maximum Annual Enterprise Value = 10.90B
Minimum Annual Increase = -26.44%
Minimum Annual Enterprise Value = 3.52B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 3.52B | -26.44% |
| 2023 | 4.78B | -23.25% |
| 2022 | 6.23B | -24.39% |
| 2021 | 8.24B | 98.20% |
| 2020 | 4.16B | -14.72% |
| 2019 | 4.87B | 1.21% |
| 2018 | 4.82B | -23.06% |
| 2017 | 6.26B | -22.89% |
| 2016 | 8.12B | -25.55% |
| 2015 | 10.90B | 121.03% |
The current Enterprise Value of Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
4.84B
5-year avg
5.38B
10-year avg
6.19B
Staidson (Beijing) BioPharmaceuticals Co., Ltd.’s Enterprise Value is less than Mabwell (Shanghai) Bioscience Co., Ltd. (18.39B), less than Yunnan Botanee Bio-Technology Group Co.LTD (16.44B), less than Anhui Anke Biotechnology (Group) Co., Ltd. (16.15B), less than Inner Mongolia Furui Medical Science Co., Ltd. (18.14B), less than DaShenLin Pharmaceutical Group Co., Ltd. (25.33B), less than Fujian Cosunter Pharmaceutical Co., Ltd. (14.73B), less than Beijing Hotgen Biotech Co., Ltd. (15.94B), less than Porton Pharma Solutions Ltd. (13.98B), less than Shenzhen Kangtai Biological Products Co., Ltd. (18.37B), less than Winning Health Technology Group Co., Ltd. (17.90B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 18.39B | $17.20B | |
| 16.44B | $17.05B | |
| 16.15B | $16.29B | |
| 18.14B | $18.61B | |
| 25.33B | $20.31B | |
| 14.73B | $14.54B | |
| 15.94B | $16.00B | |
| 13.98B | $12.73B | |
| 18.37B | $17.47B | |
| 17.90B | $18.01B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Staidson (Beijing) BioPharmaceuticals Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Staidson (Beijing) BioPharmaceuticals Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Staidson (Beijing) BioPharmaceuticals Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ)?
What is the 3-year average Enterprise Value for Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ)?
What is the 5-year average Enterprise Value for Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ)?
How does the current Enterprise Value for Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ) compare to its historical average?